AOSD

Clinical trials for AOSD explained in plain language.

Never miss a new study

Get alerted when new AOSD trials appear

Sign up with your email to follow new studies for AOSD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New drug targets deadly immune storm in rare inflammatory diseases

Disease control Completed

This study tested a drug called emapalumab in 33 children and adults with a life-threatening immune overreaction (macrophage activation syndrome) linked to Still's disease or lupus. The goal was to see if the drug could safely calm the immune system and improve blood markers and …

Matched conditions: AOSD

Phase: PHASE3 • Sponsor: Swedish Orphan Biovitrum • Aim: Disease control

Last updated May 04, 2026 16:19 UTC

AOSD

Get alerted when new AOSD trials appear

New drug targets deadly immune storm in rare inflammatory diseases